Alberto Guijosa

9PUBLICATIONS
35CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical mycologyHaematological tumoursMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Jorge J Castillo, Andrew R Branagan, Alberto Guijosa

|Mar 07, 2026
Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenström Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications.

Alberto Guijosa, Nickolas Tsakamaklis, Margaret Kobs

|Nov 19, 2025
Soluble BCMA: a window into tumor burden monitoring in Waldenström macroglobulinemia?

Alberto Guijosa, Jorge J Castillo

|Oct 21, 2025
Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia.

Andres Ramirez-Gamero, Nicholas Tsakmaklis, Zachary R Hunter

|Jul 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia.

Jorge J Castillo, Alberto Guijosa, John N Allan

|Apr 03, 2025
Current and emerging treatment perspectives for adults with Waldenström macroglobulinemia.

Alberto Guijosa, Shayna Sarosiek, Jorge J Castillo

Pageof 2